Skip to content

Mycoplasma Igg

by Trinity Biotech USA 510(k)

Active United States

510(k) K033064

Overview

The Mycoplasma IgG ELISA Kit is an Enzyme-Linked Immunosorbent Assay (ELISA) designed for the semi-quantitative or qualitative detection of IgG antibodies against Mycoplasma pneumoniae in human serum. This device aids in assessing immunological exposure to the pathogen, supporting diagnostic evaluation in microbiology.

This kit is supplied as a reusable diagnostic reagent system for laboratory use, requiring no sterilisation beyond standard aseptic handling. It is classified under FDA’s Device Class II (regulation number 866.1645) and was cleared via a Traditional 510(k) pathway (K033064). No MRI safety or single-use specifications are noted; storage and handling follow standard ELISA protocols.

AI-generated from registry data, 18 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK033064 Date26 Nov 2003ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls: none on record (FDA, checked 6 Oct 2026)

Specification

510(k)

510(k) Number
FDA Product Code
LON
Device Class
Class II
Regulation
21 CFR Part 866.1645
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

From the manufacturer

Explore Trinity Biotech's infectious disease diagnostics, including Captia™, MarDx™, and TrepSure™ assays for viral, bacterial and parasitic infections.

Source: trinitybiotech.com

Other devices from Trinity Biotech USA

See all devices from Trinity Biotech USA →

Questions

  • What is the Mycoplasma IgG ELISA Kit used for in a clinical setting?

    The Mycoplasma IgG ELISA Kit is designed for the semi-quantitative or qualitative detection of IgG antibodies against *Mycoplasma pneumoniae* in human serum. It helps clinicians assess whether a patient has been exposed to this pathogen, aiding in the diagnostic evaluation of respiratory or microbiological concerns.

  • Is this device single-use or reusable, and what are the handling requirements?

    This is a reusable diagnostic reagent system intended for laboratory use. It does not require sterilization beyond standard aseptic handling, meaning it can be used multiple times in a controlled lab environment following proper cleaning and maintenance protocols.

  • How was this device cleared by the FDA, and what regulatory pathway was followed?

    The Mycoplasma IgG ELISA Kit was cleared via the Traditional 510(k) pathway under FDA’s Device Class II (regulation number 866.1645). It was determined to be substantially equivalent to a predicate device, as indicated by the clearance type and advisory committee classification for microbiology.

  • What type of storage and handling instructions should be followed for this kit?

    The kit follows standard ELISA protocols for storage and handling, which typically include keeping it in a clean, dry environment away from direct sunlight, extreme temperatures, and contaminants. Specific instructions would align with general laboratory practices for ELISA reagents.